UNLABELLED: PURPOSE/ INTRODUCTION: The aim of this study was to determine the T1 relaxivities (r1) of 8 gadolinium (Gd)-based MR contrast agents in human blood plasma at 7 Tesla, compared with 3 Tesla. SUBJECTS AND METHODS: Eight commercially available Gd-based MR contrast agents were diluted in human blood plasma to concentrations of 0, 0.25, 0.5, 1, and 2 mmol/L. In vitro measurements were performed at 37 degrees C, on a 7 Tesla and on a 3 Tesla whole-body magnetic resonance imaging scanner. For the determination of T1 relaxation times, Inversion Recovery Sequences with inversion times from 0 to 3500 ms were used. The relaxivities were calculated. RESULTS: The r1 relaxivities of all agents, diluted in human blood plasma at body temperature, were lower at 7 Tesla than at 3 Tesla. The values at 3 Tesla were comparable to those published earlier. Notably, in some agents, a minor negative correlation of r1 with a concentration of up to 2 mmol/L could be observed. This was most pronounced in the agents with the highest protein-binding capacity. DISCUSSION/ CONCLUSION: At 7 Tesla, the in vitro r1 relaxivities of Gd-based contrast agents in human blood plasma are lower than those at 3 Tesla. This work may serve as a basis for the application of Gd-based MR contrast agents at 7 Tesla. Further studies are required to optimize the contrast agent dose in vivo.
UNLABELLED: PURPOSE/ INTRODUCTION: The aim of this study was to determine the T1 relaxivities (r1) of 8 gadolinium (Gd)-based MR contrast agents in human blood plasma at 7 Tesla, compared with 3 Tesla. SUBJECTS AND METHODS: Eight commercially available Gd-based MR contrast agents were diluted in human blood plasma to concentrations of 0, 0.25, 0.5, 1, and 2 mmol/L. In vitro measurements were performed at 37 degrees C, on a 7 Tesla and on a 3 Tesla whole-body magnetic resonance imaging scanner. For the determination of T1 relaxation times, Inversion Recovery Sequences with inversion times from 0 to 3500 ms were used. The relaxivities were calculated. RESULTS: The r1 relaxivities of all agents, diluted in human blood plasma at body temperature, were lower at 7 Tesla than at 3 Tesla. The values at 3 Tesla were comparable to those published earlier. Notably, in some agents, a minor negative correlation of r1 with a concentration of up to 2 mmol/L could be observed. This was most pronounced in the agents with the highest protein-binding capacity. DISCUSSION/ CONCLUSION: At 7 Tesla, the in vitro r1 relaxivities of Gd-based contrast agents in human blood plasma are lower than those at 3 Tesla. This work may serve as a basis for the application of Gd-based MR contrast agents at 7 Tesla. Further studies are required to optimize the contrast agent dose in vivo.
Authors: Louisa Bokacheva; Khushali Kotedia; Megan Reese; Sally-Ann Ricketts; Jane Halliday; Carl H Le; Jason A Koutcher; Sean Carlin Journal: NMR Biomed Date: 2012-07-08 Impact factor: 4.044
Authors: Valerie C Anderson; Ian J Tagge; Xin Li; Joseph F Quinn; Jeffrey A Kaye; Dennis N Bourdette; Rebecca I Spain; Louis P Riccelli; Manoj K Sammi; Charles S Springer; William D Rooney Journal: J Neuroimaging Date: 2020-06-17 Impact factor: 2.486
Authors: L Umutlu; S Maderwald; S Kinner; O Kraff; A K Bitz; S Orzada; S Johst; K Wrede; M Forsting; M E Ladd; T C Lauenstein; H H Quick Journal: Eur Radiol Date: 2012-10-14 Impact factor: 5.315
Authors: Lale Umutlu; Oliver Kraff; Anja Fischer; Sonja Kinner; Stefan Maderwald; Kai Nassenstein; Felix Nensa; Johannes Grüneisen; Stephan Orzada; Andreas K Bitz; Michael Forsting; Mark E Ladd; Thomas C Lauenstein Journal: Eur Radiol Date: 2013-05-04 Impact factor: 5.315
Authors: Ergys Subashi; Everett J Moding; Gary P Cofer; James R MacFall; David G Kirsch; Yi Qi; G Allan Johnson Journal: Med Phys Date: 2013-02 Impact factor: 4.071